Back to today’s briefing

Story perspectives

Artis BioSolutions Acquires Landmark Bio to Enhance Manufacturing

4/2/2025

46 4

Summary

Story summary

Artis BioSolutions has made a strategic move by acquiring Landmark Bio, a Massachusetts-based company, to boost its advanced therapy manufacturing capabilities. Landmark will maintain its independent operations, while this acquisition promises to accelerate the development of genetic medicines and broaden access to top-notch manufacturing services. Artis, established in 2024, has already poured $250 million into this vital sector.

1 of 1

Story summary

Artis BioSolutions has made a strategic move by acquiring Landmark Bio, a Massachusetts-based company, to boost its advanced therapy manufacturing capabilities. Landmark will maintain its independent operations, while this acquisition promises to accelerate the development of genetic medicines and broaden access to top-notch manufacturing services. Artis, established in 2024, has already poured $250 million into this vital sector.